tirzepatide and progesterone HRT Weight Loss Injections in Menopause Interaction between GLP-1 Inhibitors and

Glucocorticoid-induced hyperglycemia: A neglected problem

GLP-1 agonists are not suitable for everyone and there are specific criteria you will need to meet to get a prescription

Semaglutide treatment can prevent calorie excess and contributes to improved dietary choices

A landmark 2022 randomized controlled trial published in the European Journal of Endocrinology by Handelsman and colleagues followed men who stopped two years of testosterone undecanoate injections

Clinical findings suggest the long-term effectiveness and safety of semaglutide as a weight loss agent in non-diabetics, with sustained weight loss over a two-year period and few hypoglycemic events noted